IGHG3 and erythema multiforme: In contrast to (typically polysaccharide-specific) IgG2, which has been previously described as the dominant subclass of MOG-IgG in single patients with suspected MOG-EM/MOGAD [6], IgG3 (which mainly recognizes proteins) is a strong complement activator (even stronger than IgG1).